Dennis L. Vargo

Dennis L. Vargo has extensive experience in the field of drug safety and pharmacovigilance. Dennis L. most recently served as the Vice President and Head of Drug Safety and Pharmacovigilance at Akebia Therapeutics since November 2018. Prior to that, they held the role of Global Safety Lead, Early Oncology at Takeda Oncology starting in March 2017. Dennis L. also worked as the Vice President and Head of Pharmacovigilance at TESARO, Inc. and Clovis Oncology. Additionally, Dennis has held various positions at Pharmaceutical Safety Consultant, AVEO Pharmaceuticals, UCB, Pfizer, and AstraZeneca.

Dennis L. Vargo's education history begins in 1978 when they attended Brandeis University. Dennis L. completed their Bachelor's degree in Philosophy in the year 1980. Afterward, from 1981 to 1985, Dennis pursued their medical education at Indiana University School of Medicine, where they earned a Doctor of Medicine (MD) degree with a specialization in Medicine. Additionally, it is mentioned that Dennis attended the United States Naval Academy, although the specific dates and degree earned are unknown. At this institution, they likely completed an Associate's degree and studied subjects such as Engineering and English. Lastly, it is also mentioned that Dennis spent time at the American College in Paris, but no degree or field of study is provided for this particular experience.